Delivery Order SPE2DB22D2206-SPE2DB25FFQ62
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a medical product, with a ceiling value of $21,220.56 and a completion date of April 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,262.85, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of July 14, 2025. The contract is a Firm Fixed Price agreement and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,957.71 and a period of performance through April 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,957.71 and a period of performance through April 2, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,830.84, is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price pricing type and runs through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a total ceiling value of $7,957.71. The contract is a firm fixed price, non-set-aside award with a completion date of July 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $2,652.57 and a completion date of June 13, 2025. The contract is a Firm Fixed Price type, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,915.42, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period that extends through May 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $15,915.42 delivery order contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price Delivery Order, with a period of performance through July 30, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $15,915.42 and a completion date of June 12, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is also the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FFQ62Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $21,220.56. The contract has an ultimate completion date of March 7, 2025 and was awarded on February 13, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 2/13/25 |